StonvexLoading…
StonvexStonvexStonvexCore line items from APVO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-10 | Annual 2022 2022-12-31 | Q3 2022 2022-09-30 | Q2 2022 2022-06-30 | Q1 2022 2022-03-31 |
|---|---|---|---|---|---|
Revenue | $0.00 | $3.11M | $3.11M | $3.11M | $3.11M |
Operating Income | Not available | $-28.64M | $-20.96M | $-13.17M | $-5.61M |
Net Income | Not available | $8.03M | $12.67M | $28.01M | $-7.70M |
EPS (Diluted) | $-6.32 | $1.57 | $2.52 | $4.08 | $-1.55 |
Total Assets | Not available | $34.22M | $31.70M | $38.80M | $45.18M |
Total Liabilities | Not available | $16.24M | $15.93M | $15.75M | $51.07M |
Cash & Equivalents | Not available | $22.64M | $22.15M | $29.43M | $34.99M |
Free Cash Flow OCF − CapEx | Not available | $-21.05M | $-15.11M | $-8.21M | Not available |
Shares Outstanding | Not available | 6.47M | 5.09M | 5.09M | 5.01M |